Merck KGaA Logo

Merck KGaA

A science & tech firm in healthcare, life science, and electronics, advancing human progress.

6MK | F

Overview

Corporate Details

ISIN(s):
DE0006599905 (+71 more)
LEI:
4YV9Y5M8S0BRK1RP0397
Country:
United States of America
Address:
126 East Lincoln Avenue, 07065-1310 Rahway
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Merck KGaA is a leading science and technology company that operates across Healthcare, Life Science, and Electronics. The Healthcare division discovers, develops, and manufactures prescription drugs and therapies for conditions such as cancer, multiple sclerosis, and infertility. The Life Science business collaborates with the global scientific community, providing tools and services to solve complex problems in research and biotech production. Its Electronics division supplies specialty chemicals and materials for demanding applications. Founded in 1668, Merck KGaA is the world's oldest operating chemical and pharmaceutical company, leveraging a long history of research and innovation to advance technology and improve lives.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-01 00:00
Interim Report
Half-yearly financial report 2025
English 999.9 KB
2025-08-13 17:39
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-08-05 23:02
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-14 15:01
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-08 18:21
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-07 11:28
Declaration of Voting Results & Voting Rights Announcements
English 81.2 KB
2025-07-04 13:25
Declaration of Voting Results & Voting Rights Announcements
English 81.3 KB
2025-07-03 10:58
Declaration of Voting Results & Voting Rights Announcements
English 75.7 KB
2025-06-13 15:37
Major Shareholding Notification
English 12.2 KB
2025-06-13 13:23
Declaration of Voting Results & Voting Rights Announcements
English 13.3 KB
2025-06-10 10:31
Declaration of Voting Results & Voting Rights Announcements
English 78.1 KB
2025-06-05 08:43
Declaration of Voting Results & Voting Rights Announcements
English 13.4 KB
2025-05-19 00:00
Quarterly Report
Q1 statement / Q1 financial report 2025
English 809.0 KB
2025-05-06 13:33
Declaration of Voting Results & Voting Rights Announcements
German 20.8 KB
2025-04-26 14:13
Declaration of Voting Results & Voting Rights Announcements
German 20.8 KB

Automate Your Workflow. Get a real-time feed of all Merck KGaA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Merck KGaA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.